INS and Hyperglycemia: Numerous studies have evaluated β-cell function (BCF) under a variety of metabolic and clinical conditions, and there is strong evidence to indicate that, once the over-secretion of insulin can no longer compensate for the degree of insulin resistance, hyperglycemia becomes clinically significant and the deterioration of the residual β-cell reserve is accelerated.